Physician

Mustafa Ibrahim Musa, M.D.

According to 2025 Medicare claims, Mustafa Musa, M.D. (NPI: 1033126164) practices internal medicine in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is BEAUMONT INTERNAL MEDICINE & GERIATRIC ASSOC. (NPI: 1164430906; TIN: 741903407) and primary practice location at 77702-1522.

Musa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 15,127 HCPCS/CPT codes, and received $304,845 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 16,701 prescription claims across 848 beneficiaries totaling $1,249,312 in drug costs, led by Ozempic (Semaglutide). DME data shows 830 claims. Open Payments data shows 9 records totaling $167. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $559,580 to $304,845. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $54,850 to $43,963.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	586	24,129	$559,580
2016	763	23,667	$567,735
2017	677	19,234	$458,438
2018	623	19,679	$464,804
2019	664	20,473	$484,493
2020	544	17,171	$345,043
2021	530	16,697	$408,649
2022	466	16,889	$348,579
2023	452	16,260	$332,130
2024	435	15,127	$304,845

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	810	22,672	$1,182,361
2016	765	22,888	$1,208,954
2017	815	20,158	$1,113,151
2018	821	17,795	$1,011,007
2019	798	17,681	$1,090,126
2020	776	18,281	$1,193,222
2021	866	19,586	$1,340,814
2022	898	18,816	$1,250,411
2023	779	17,283	$1,275,087
2024	848	16,701	$1,249,312

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	669	1,675	$59,370
2016	590	1,700	$55,327
2017	456	1,124	$28,976
2018	344	980	$29,004
2019	396	1,252	$61,800
2020	336	1,046	$28,344
2021	299	952	$36,239
2022	208	725	$23,157
2023	210	725	$35,776
2024	291	830	$53,218

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	341	923	$16
80061	Blood test, lipids (cholesterol and triglycerides)	344	922	$13
80053	Blood test, comprehensive group of blood chemicals	344	953	$10
83036	Hemoglobin a1c level	341	906	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	343	956	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	257	8,526	$265,910
Eliquis	Apixaban	151	8,450	$156,810
Avonex Pen (4 Pack)	Interferon Beta-1a	11	308	$89,359
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	95	3,600	$75,386
Xarelto	Rivaroxaban	42	2,820	$51,025

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	12	$11,255
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	26	$10,357
A7030	Full face mask used with positive airway pressure device, each	N	30	56	$4,639
A7031	Face mask interface, replacement for full face mask, each	N	20	45	$3,603
E0601	Continuous positive airway pressure (cpap) device	Y	25	119	$3,528

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$167	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mustafa Ibrahim Musa, M.D.?

Tedicare shows public-source Medicare data for Mustafa Ibrahim Musa, M.D. (NPI 1033126164), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mustafa Ibrahim Musa, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mustafa Ibrahim Musa, M.D.?

Mustafa Ibrahim Musa, M.D. is linked to BEAUMONT INTERNAL MEDICINE & GERIATRIC ASSOC. (billing NPI 1164430906) in the available physician profile data.

Does Mustafa Ibrahim Musa, M.D. have Open Payments data?

Mustafa Ibrahim Musa, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.